| Literature DB >> 32455747 |
Marine Remize1, Frédéric Planchon1, Ai Ning Loh2, Fabienne Le Grand1, Antoine Bideau1, Nelly Le Goic1, Elodie Fleury3, Philippe Miner3, Rudolph Corvaisier1, Aswani Volety4, Philippe Soudant1.
Abstract
: The present study sought to characterize the synthesis pathways producing theEntities:
Keywords: 20:5n-3 (EPA), Chaetoceros muelleri; acyl-editing mechanism; compound-specific isotope analysis; diatom; synthesis pathway
Mesh:
Substances:
Year: 2020 PMID: 32455747 PMCID: PMC7277837 DOI: 10.3390/biom10050797
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Figure 1Fatty acids synthesis in diatoms. Desaturases are noted with “ω” and/or “Δ” and refer to the location of carbon holding the newly formed double bond and its position within the methyl or front end of the acyl chain (2 types, methyl-end (grey or blue arrows) or front-end desaturases (yellow arrows)). Des: desaturase, Elo: elongase, FAS: fatty acid synthase.
Figure 2Experimental design of the enrichment experiment. The 13CO2 is supplied to the culture using a pH-stat system. To prevent contamination when sampling the algae, pliers are used to close/open the tubes/ways needed to first put the balloon under pressure and then allow sampling and finally rinse the tubes after collection.
List of international and in-house standards used for EA-IRMS and GB-IRMS analysis. IAEA: International Atomic Energy Agency.
| Description | Nature | Analysis | δ13C (‰) | SD |
|---|---|---|---|---|
| IAEA-CH6 | Sucrose (C12H22O11) | 13C-POC | −10.45 | 0.03 |
| IAEA-600 | Caffeine (C8H10N4O2) | 13C-POC | −27.77 | 0.04 |
| Acetanilide | Acetanilide (C8H9NO) | 13C-POC | 29.53 | 0.01 |
| CA21 (in-house std) | Calcium carbonate (CaCO3) | 13C-DIC | +1.47 | |
| Na2CO3 (in-house std) | Sodium carbonate | 13C-DIC | −6.88 | |
| NaHCO3 (in-house std) | Sodium bicarbonate | 13C-DIC | −5.93 |
Groups of fatty acids formed according to their main pathways.
| Group | Fatty Acids Concerned |
|---|---|
| C16 PUFAs pathway | 16:2n-7/16:2n-4/16:3n-4/16:4n-1 |
| n-3 pathway | 18:3n-3/18:4n-3/20:4n-3/20:5n-3/22:5n-3/22:6n-3 |
| n-6 pathway | 18:2n-6/18:3n-6/20:2n-6/20:3n-6/20:4n-6/22:2n-6/22:5n-6 |
| FAS and post FAS | 16:0/18:0/16:1n-7/18:1n-9 |
| Bacterial FA | 15:0/17:0/iso15:0/iso17:0/17:1n-7 |
Figure 3Dynamics of cell concentrations of the two enriched balloons of Chaetoceros muelleri (mean ± SD; solid line ● n = 2) and of the control balloon (solid line ○) (a) and the corresponding bacteria concentrations (b) during the 24 h experiment.
Cellular parameters of C. muelleri using flow cytometry analysis (Mean ± SD, n = 3) according to sampling time. Control and enriched balloons were combined for this table as no differences were observed between balloons. Values for FDA and SYTOX are in %, values for BODIPY/FL3/SSC/FSC in arbitrary unit (a.u).
| FL1-FDA | FL1-SYTOX | FL1-BODIPY (a.u) | FL3 | SSC | FSC | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 93 | ± | 4 | 99 | ± | 1 | 160 | ± | 20 | 263 | ± | 2 | 48 | ± | 1 | 149 | ± | 0 |
| 0.5 | 90 | ± | 4 | 99 | ± | 1 | 215 | ± | 23 | 274 | ± | 20 | 50 | ± | 2 | 152 | ± | 1 |
| 1 | 93 | ± | 3 | 99 | ± | 0 | 233 | ± | 31 | 276 | ± | 18 | 56 | ± | 10 | 151 | ± | 2 |
| 2 | 93 | ± | 2 | 100 | ± | 0 | 209 | ± | 11 | 275 | ± | 19 | 57 | ± | 10 | 153 | ± | 1 |
| 3 | 93 | ± | 2 | 100 | ± | 0 | 245 | ± | 25 | 263 | ± | 3 | 53 | ± | 2 | 152 | ± | 1 |
| 4 | 92 | ± | 1 | 98 | ± | 2 | 248 | ± | 26 | 260 | ± | 2 | 53 | ± | 1 | 152 | ± | 2 |
| 6 | 92 | ± | 2 | 98 | ± | 2 | 194 | ± | 17 | 260 | ± | 2 | 50 | ± | 2 | 152 | ± | 1 |
| 8 | 90 | ± | 1 | 98 | ± | 3 | 248 | ± | 17 | 260 | ± | 2 | 53 | ± | 2 | 153 | ± | 3 |
| 10 | 90 | ± | 1 | 98 | ± | 2 | 157 | ± | 2 | 262 | ± | 3 | 52 | ± | 3 | 153 | ± | 1 |
| 12 | 89 | ± | 4 | 99 | ± | 1 | 163 | ± | 26 | 262 | ± | 4 | 51 | ± | 2 | 154 | ± | 0 |
| 14 | 89 | ± | 2 | 97 | ± | 4 | 276 | ± | 24 | 261 | ± | 4 | 53 | ± | 0 | 156 | ± | 1 |
| 16 | 86 | ± | 3 | 97 | ± | 3 | 284 | ± | 9 | 261 | ± | 4 | 52 | ± | 2 | 155 | ± | 1 |
| 18 | 87 | ± | 2 | 98 | ± | 3 | 163 | ± | 11 | 259 | ± | 6 | 52 | ± | 3 | 156 | ± | 3 |
| 20 | 88 | ± | 4 | 99 | ± | 2 | 308 | ± | 9 | 258 | ± | 6 | 56 | ± | 1 | 155 | ± | 1 |
| 22 | 87 | ± | 4 | 96 | ± | 5 | 269 | ± | 16 | 258 | ± | 5 | 55 | ± | 2 | 154 | ± | 1 |
| 24 | 88 | ± | 3 | 99 | ± | 2 | 239 | ± | 5 | 257 | ± | 6 | 54 | ± | 1 | 154 | ± | 2 |
Figure 4Dynamics of Particulate Organic Carbon concentration (a) and of Total Fatty Acids concentration (b) for the two enriched balloons Cm1 and Cm2 (Cm = Chaetoceros muelleri) (mean ± SD; n = 3). The blue line corresponds to increasing trend between t0 and t24 (POC: y = 0.27x + 14, R2 = 76% p-value < 0.001; TFA: y = 0.08x + 2.5, R2 = 93% p-value < 0.001). POC concentration relationships with algae concentration (c) (eq: y = 2.4x − 5.7 R2 = 79%, p-value < 0.001) and with total fatty acid concentration (d) (eq: y = 0.23x − 0.5, R2 = 80%, p-value < 0.001) (mean; n = 3). Points below 8 × 106 cells·mL−1 are not included in the linear regression and are considered as outliers (corresponding to t0.5 and t1 in Figure 3).
Figure 5Atomic enrichment (AE) of the Dissolved Inorganic Carbon (a). Atomic enrichment (AE) of Particulate Organic Carbon (b) (Cm = Chaetoceros muelleri).
Figure 6Proportions (% of Total Fatty Acids) of main fatty acids in neutral lipids (NL) and polar lipids (PL) of C. muelleri. (Mean ± SD n = 16 for each fraction). Among the 44 identified fatty acids (FA), only those accounting for more than 1% of the TFA are represented here (between 0.1% and 1%, 15:0, 18:0, 22:0, 14:1n-5, 16:1n-5, 22:2n-6 were detected in both neutral and polar lipids, iso15:0, 24:0, 16:1n-9, 17:1n-7, 16:2n-6 and 16:4n-3 were detected in neutral lipids and 18:1n-11, 18:1n-5, 16:4n-1, 18:3n-4, 20:3n-6, 20:4n-3 and 22:5n-3 were detected in polar lipids). The proportions of the 10 presented FA were significantly different between neutral lipids and polar lipids.
Figure 7Principal component analyses (PCA) made with %mass for all the fatty acids in the polar fraction (PL) (a) and the neutral fraction (NL) (b). Only the FA selected by SIMPER analysis are shown here (explaining 80% of the variability). The colors represent the different sampling times from t0 to t24, and the symbols represent the balloons considered. Cm1 and Cm2 are the enriched balloons, CmT the control balloon (Cm = Chaetoceros muelleri, n = 48 for NL and n = 48 for PL).
Figure 8FA concentration dynamics in neutral lipid fraction (NL—left) and polar lipid fraction (PL—right) with time for the two most abundant C16 fatty acids (16:0 and 16:1n-7), and the two end-product fatty acids (16:3n-4 and 20:5n-3) for the three culture balloons. Cm1 and Cm2 are the enriched balloons, and CmT is the control balloon (Cm = Chaetoceros muelleri).
Figure 9Atomic enrichment of the 10 most abundant FA in polar lipids (PL) and neutral lipids (NL) and suspected as involved in PUFA synthesis in C. muelleri. The standard deviation represents the variability between enriched balloons (Cm1 and Cm2, Cm = Chaetoceros muelleri).
Figure 10Specific uptake rates calculated with AE (µFA) of the 10 studied fatty acids in polar lipids (PL) and neutral lipids (NL) of C. muelleri (n = 2 for each).
Mean ratio of atomic enrichment (AE) for pairs of FA (FAA vs. FAB) in neutral lipids (NL) and polar lipids (PL) (Mean ± SD, n = 10 sampling dates) for the two enriched balloons (Cm1, Cm2; Cm = Chaetoceros muelleri). If the ratio is equal to or close to 1, A and B are assumed at equilibrium, and B is synthesized quickly from A; if the ratio is below 1, the transformation of B from A is possible but slow. Finally, if the ratio is above 1, A is not the main precursor of B, which has to be synthesized by a different pathway.
| Neutral Lipids | Polar Lipids | |||||||
|---|---|---|---|---|---|---|---|---|
| Cm1 | Cm2 | Cm1 | Cm2 | |||||
| Fatty acid B/Fatty acid A | Mean | SD | Mean | SD | Mean | SD | Mean | SD |
| 18:1n-9/18:0 | 0.37 | 0.03 | 0.41 | 0.05 | 5.72 | 2.16 | 5.89 | 2.14 |
| 18:2n-6/18:1n-9 | 2.25 | 0.15 | 2.03 | 0.27 | 1.00 | 0.06 | 0.98 | 0.07 |
| 18:3n-6/18:2n-6 | 1.23 | 0.14 | 1.26 | 0.11 | 0.83 | 0.10 | 0.85 | 0.08 |
| 20:4n-6/18:3n-6 | 0.33 | 0.05 | 0.29 | 0.09 | 0.43 | 0.09 | 0.41 | 0.10 |
| 20:5n-3/18:4n-3 | 0.18 | 0.05 | 0.13 | 0.05 | 0.18 | 0.02 | 0.15 | 0.04 |
| 18:4n-3/18:3n-6 | 0.77 | 0.20 | 0.82 | 0.20 | 0.62 | 0.06 | 0.61 | 0.08 |
| 20:5n-3/20:4n-6 | 0.40 | 0.09 | 0.37 | 0.12 | 0.26 | 0.03 | 0.23 | 0.04 |
| 16:1n-7/16:0 | 0.63 | 0.03 | 0.63 | 0.01 | 0.58 | 0.03 | 0.57 | 0.03 |
Figure 11Summary of FA synthesis relationships in polar and neutral lipids pools for C. muelleri according to ratio calculation results. The solid arrows correspond to ratios of fatty acid B and suspected precursor A that are equal to or below 1, and red crosses correspond to ratios above 1. The fatty acids in grey were absent or present in trace amounts in this experiment, and consequently, the ways marked by dashed arrows were not possible to verify.
Figure 12Hypothesized synthesis of phosphatidylcholine (PC) and triacylglycerol (TAG) in C. muelleri. CoA: co-enzyme A, CPT: cytidine-5′-diphosphate choline phosphotransferase, DAG: diacylglycerol, DGAT: acyl-CoA DAG acyltransferase, G3P: glycerol-3-phosphate, GPAT: acyl-CoA-glycerol-3-phosphate acyltransferase, LPA: lysophosphatidic acid, LPC: lysophosphatidylcholine, LPAAT: acyl-CoA-lysophosphatidic-acid- acyltransferase, LPCAT: acyl-CoA LPC acyltransferase, PA: phosphatidic acid, PAP: acyl-CoA-phosphatidic acid phosphatase, PC (P-Cho): phosphatidylcholine, PDAT: phospholipid:DAG acyltransferase, TAG: triacylglycerol. Δ9, Δ12, Δ6 desaturases.
Figure 13Hypothesized pathway for the production of prokaryotic glycolipids in C. muelleri. Two pathways can produce DAG: one is located in the chloroplast (prokayotic pathway), the other in the endoplasmic reticulum (ER) (eukaryotic pathway). The 20:5n-3-CoA used for glycolipids synthesis is produced in the ER and collected from it to form prokaryotic DAG. This DAG can be further used to create glycolipids (configuration sn-1: 20:5n-3 and sn-2: 16:3n-4). The eukaryotic pathway in the ER could also explain the similar concentration dynamics observed between 20:5n-3 and 18:4n-3. CoA: co-enzyme A. DAG: diacylglycerol, DGD: digalactodiacylglycerol synthase, DGDG: digalactodiacylglycerol, G3P: glycerol-3-phosphate, GPAT: acyl-CoA-glycerol-3-phosphate acyltransferase, LPA: lysophosphatidic acid, LPAAT: acyl-CoA-lysophosphatidic-acid-acyltransferase, MGD: monogalactodiacylglycerol synthase, MGDG: monogalactodiacylglycerol, PA: phosphatidic acid, PAP: acyl-CoA-phosphatidic acid phosphatase, PC: phosphatidylcholine.